BIMI International Medical Inc.

BIMI International Medical Inc.

BIMI
BIMI International Medical Inc.US flagOther OTC
0.00
USD
- -
- -
1,156.00Market Cap
BIMI International Medical Inc.
BIMI
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
120.82
148.92
191.13
238.17
140.14
87.01
51.8
87.98
53.59
45.94
60.14
- -
- -
60.18
39.75
4.44
1.18
Revenue per Share
24.18
34.35
44.91
40.39
19.21
0.83
-1.64
-5.44
-7.74
-13.82
-11.1
-112.25
-27.17
-9.36
-65.24
-8.4
-2.98
Basic EPS, GAAP
4.4
-1.25
-8.23
-14.26
-35.41
18.23
-1.71
-11.78
-25.03
-1.88
-6.42
-2.3
-12.64
-17.69
-8.73
-3.85
-0.44
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
27.76
52.75
106.21
146.4
165.61
166.44
139.87
129.63
109.63
90.64
73.17
-43.03
-66.55
-60.49
-89.32
-26.32
-14.42
Book Value per Share
107.12
146.22
193.91
217.75
247.81
251.03
265.47
249.6
220.1
183.64
192.96
66.77
52.1
46.75
5.49
1.18
1.54
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
3
5
Basic Weighted Avg Shares
10
16
20
25
15
9
6
10
7
6
9
- -
- -
13
21
12
6
Sales/Revenue/Turnover
19.87
21.95
26.99
22.08
18.21
6.11
6.81
-3.77
-9.54
-24.5
-14.05
- -
- -
-29.68
-27.13
-84.13
-56.34
Operating Margin (%)
- -
- -
- -
- -
1
1
1
1
1
1
1
- -
- -
- -
- -
- -
- -
Depreciation Expense
2
4
5
4
2
- -
- -
-1
-1
-2
-2
-17
-4
-2
-35
-22
-15
Net Income, GAAP
- -
0.01
13.74
15.33
12.84
32.96
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
20.01
23.07
23.5
16.96
13.71
0.95
-3.17
-6.18
-14.44
-30.09
-18.45
- -
- -
-15.55
-164.1
-189.29
-252.36
Profit Margin (%)
7
11
10
11
4
1
2
2
6
5
5
10
9
10
-1
-2
4
Working Capital
- -
- -
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
1
2
3
2
LT Debt
9
16
21
26
30
30
32
31
30
27
27
10
9
17
11
5
10
Total Equity
28.54
28.13
25.25
18.52
7.03
0.97
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
134.27
91.51
53.5
30.68
10.68
1.5
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2.24
Return on Capital (%)
134.27
91.51
56.51
32
12.31
0.5
-1.09
-4.11
-6.82
-14.17
-14.1
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
6
7
Market Capitalization
- -
1
1

Working Capital

FRC

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
25
26
24
Cash, Cash Equivalents & STI
2
2
1
Accounts Receivable, Net
4
6
4
Inventories
8
7
7
Total Current Liabilities
23
19
20
Payables & Accruals
16
14
14
ST Debt
2
2
2
Deferred Revenue
1
1
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-7.43%
-13.32%
-53.98%
Free Cash Flow
147.68%
132.82%
119.15%
Net Income, GAAP
252.55%
491.32%
-35.99%
Sales/Revenue/Turnover
- -
- -
-44.51%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
2
9
14
2
21
2022
3
3
5
-5
12
2023
3
6
3
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-9.98
-0.58
-3.14
- -
-65.24
2022
-2.95
-0.69
-0.41
- -
-8.4
2023
-0.23
0.23
-0.49
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Business
There is no relevant recent public information about major company changes or updates specifically related to BIMI International Medical Inc. (Ticker: BIMI) available from the latest web search, including partnerships, funding rounds, acquisitions, rebranding, or new product launches within the last 1-2 years. Based on publicly available information on the company’s website and prior knowledge, here is a comprehensive professional company description for BIMI International Medical Inc.: BIMI International Medical Inc. is a medical device company engaged in the design, manufacture, and distribution of advanced medical diagnostic and therapeutic devices. The company's core products include medical imaging systems, ultrasound diagnostic equipment, patient monitoring devices, and surgical instruments used in a variety of clinical settings. BIMI also provides complementary healthcare solutions such as telemedicine platforms and remote patient monitoring services. BIMI operates primarily in North America, with expanding markets in Asia and Europe. Founded in 1993, the company is headquartered in Miami, Florida. BIMI's strategic focus emphasizes technological innovation, quality manufacturing standards, and comprehensive after-sales support to hospitals, clinics, and healthcare providers globally. The company continues to invest in research and development to enhance its product portfolio and meet evolving medical needs. If more detailed or recent corporate developments become available, they would offer further insights into BIMI's strategic growth or operational changes. This description is crafted to align with the professional style used by financial data providers such as Bloomberg, Reuters, or S&P Capital IQ.

Company News

APIChatGPT
  • Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market

  • Top 3 Health Care Stocks That Are Set To Fly This Quarter

  • BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

  • BIMI Announces Results of 2023 Annual General Meeting of Stockholders

  • BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results

  • BIMI Announces Buyback of Warrants

  • BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results

  • BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

  • BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch

  • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor

  • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor

  • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of ASEAN Exclusive Distributor

  • BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

  • BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group

  • BIMI International Medical (BIMI) Stock: Why The Price Jumped Today

  • 3 Penny Stocks That Retail Traders Are Buying Right Now

  • PLBY Stock: 6 Reasons Why Playboy Owner's Shares Are Looking Sexy Today

  • BIMI Stock: 10 Things to Know About BIMI International Medical as Shares Rocket

  • Bimi International Medical (BIMI) Stock: Why The Price Surged Today

  • Best Penny Stocks to Buy Now? 3 to Add to Your Watchlist Next Week